Division of Teva Pharmaceutical Industries Ltd.
Latest From Actavis Laboratories
The US FDA finds metformin meets NDMA impurity threshold and urges diabetics to continue taking it.
Norway becomes the latest country to reverse-switch diclofenac in response to a 2018 study linking low doses of the drug to cardiovascular adverse events.
Oral diclofenac will no longer be available without a prescription in Sweden after the national drug regulator judged that the potential adverse event risks were too high to justify continued OTC supply. Products from GSK and Mylan will be affected by the decision.
A topical foam formulation of the antibiotic, minocycline, is expected to be a novel entrant into the US severe acne market. After positive top-line results from a confirmatory Phase III study, Foamix is stepping-up its financing and marketing plans.
- Controlled Release
- Generic Drugs
- Drug Delivery
- Therapeutic Areas
- Andrx Corp.
- North America
- Parent & Subsidiaries
- Teva Pharmaceutical Industries Ltd.
- Senior Management
Nicholas F Cappuccino, PhD, EVP, CSO
Jeffrey Long-McGie, VP, Bus. Dev.
- Contact Info
Phone: (954) 382-7600
8151 Peters Rd.
Davie, FL 33314